The Medicine Maker

17/12/2025

🧬 Can cell and gene therapies live up to their promise?

From next-generation CAR-Ts to the politics shaping global biotech, our latest eBook — Cell and Gene Therapy: Hope, Hype and Political Upheaval — explores how innovation and uncertainty are redefining the future of medicine.

📘 Download your copy now and discover insights from leading experts in the field: https://ow.ly/jj9T50Xkf7r

Sponsored by 4basebio and Evotec

15/12/2025

Our new supplement brings together leaders from industry, academia, and clinical practice to examine what it will take to industrialize advanced therapies.

Topics include:
🔸 Trends in gene editing and next-generation CAR-T

🔸 How the sector is addressing manufacturing and workforce bottlenecks

🔸 Strategic perspectives on access, cost, and global deployment

🔸 The role of digital twins and data-driven platforms in future manufacturing models

🔸 Leadership insights from Oxford Biomedica’s CEO, Frank Mathias

Download the supplement here: https://ow.ly/5XzL50XHm0V

Kindly sponsored by Lonza and Evotec

09/12/2025

How far can curiosity take a scientist? 🚀🔬

From the University of Houston to MD Anderson Cancer Center, Cole Woody’s journey shows how collaboration and bold questions can spark major breakthroughs.

His latest work explores the potential of repurposed mRNA vaccines, the technical craft behind immunology, and why the social side of science matters more than ever.

Read the full article: https://ow.ly/r3PQ50Xy3ro

From the University of Houston to MD Anderson Cancer Center, Cole Woody’s journey shows how curiosity and collaboration can drive major discoveries. He reflects on the promise of repurposed mRNA vaccines, the technical art of immunology, and the social side of science.

04/12/2025

💡 Could antibody therapeutics reshape infertility treatment?

In a new feature, Marie-Christine Maurel explores IGX12 — a monoclonal antibody that enhances FSH bioactivity and shows promising effects in both male and female models.

Early phase 1 data report strong safety, opening the door to a new class of infertility therapies that could reduce the burden on women and expand options for men.

Read more: https://ow.ly/8rnh50XuzNS

03/12/2025

🚨 Tomorrow: Smarter CHO Strategies for Bispecific Success!

It’s almost time! Don’t miss Senior Scientist Yiting Lim from Just - Evotec Biologics revealing how next-gen CHO systems are delivering faster, cleaner, antibiotic-free bispecific production.

Get ready for real-world insights, proven results, and actionable strategies you can use immediately.

📅 Tomorrow – Thursday, Dec 4 | 4 PM GMT / 11 AM ET / 8 AM PT
🎟️ Register free before it’s too late: https://ow.ly/KHGR50XpaVw

02/12/2025

New research urges clinicians to rethink routine tablet crushing in stroke dysphagia.

Researchers found whole tablets given with a soft bolus were often swallowed safely, while crushed tablets increased residue and risk.

Expert Michaela Trapl-Grundschober shares why FEES-based assessment should guide medication decisions.

Full story: https://ow.ly/RiVr50XuAXs

27/11/2025

📣 Just 1 week to go!

🚀 Join our webinar on December 4 to transform your bispecific antibody production with smarter CHO strategies!

Yiting Lim from Just - Evotec Biologics will explore:
✅ Higher yields & cleaner production
✅ Antibiotic-free GS-only systems
✅ Real-world continuous manufacturing results

Don’t miss this free webinar!
📅 Dec 4 | 4 PM GMT

Register before it's too late 🔗 https://ow.ly/e14t50XpbjF

26/11/2025

What does it take to turn an experimental idea into a global therapy?

In an exclusive interview, Bruce Levine, co-founder of the first CAR T-cell trials and a pioneer of Kymriah, shares his journey from childhood curiosity to translational success.

Levine reflects on building the foundations of cell and gene therapy, the importance of communication and regulatory collaboration, and why the field’s next leap will depend on global cooperation between scientists, regulators, and industry.

Read the full interview:
🔗 https://ow.ly/ieHI50XorfV

24/11/2025

The future of biologics is here — but making it work is no small feat.

In our latest feature, leaders from Lonza — David Schmitt, Flora Felsovalyi, Orla McGarvey, and Michael Jahn — break down the challenges of formulating stable, high-concentration biologics for prefilled syringes and autoinjectors.

From viscosity and aggregation to device compatibility and patient usability, they share strategies that can de-risk development and accelerate timelines.

👉 Read the full article: https://ow.ly/a2bX50WUB2u

21/11/2025

🚀 Now Available On Demand!

Missed the live session? You can now watch our exclusive webinar From Lab to Launch: Innovating Life Science & Diagnostics Product Development — anytime, anywhere.

Discover how precision glycosylation and advanced biocatalysis are revolutionizing biopharma development, from improving therapeutic protein quality to driving greener API synthesis.

🎓 Key insights include:
🔹 Using fluorinated monosaccharides to control glycosylation patterns
🔹 Leveraging biocatalysts for sustainable manufacturing
🔹 Bridging chemistry and biology for real-world innovation

🎙 Featuring experts from Biosynth:
Thanos Andreou | Jan Modregger | Aileen White

▶️ Watch on demand now: https://ow.ly/Snns50XcpLs

20/11/2025

💊 “The next crisis will again favor those who invest in strong, multi-tiered partnerships.”

Are pharma supply chains truly ready for the next black swan event?
Resilience is no longer just about stockpiles — it’s about strategy, data, and collaboration.

Read the full piece 👉 https://ow.ly/yM6Z50XpPBj